Evidence map›Paper›PMID 36279370›Full record

ArticleChemistry & biodiversity2022

NetCellMatch: Multiscale Network-Based Matching of Cancer Cell Lines to Patients Using Graphical Wavelets.

Neel Desai, Jeffrey S Morris, Veerabhadran Baladandayuthapani

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Neel DesaiDivision of Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.ORCID http://orcid.org/0000-0002-4170-494X
Jeffrey S MorrisDivision of Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Veerabhadran BaladandayuthapaniDepartment of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA.

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4M
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic CancerP50CA221707 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KOPETZ, SCOTT, MAITRA, ANIRBAN · 2019 to 2023
$11.0M
Bayesian Network-Based Integrative Genomics Methods for Precision MedicineR01CA244845 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BALADANDAYUTHAPANI, VEERABHADRAN, MORRIS, JEFFREY S · 2021 to 2024
$1.8M
Bayesian methods for complex, high-dimensional functional data in cancer researchR01CA178744 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MORRIS, JEFFREY S · 2015 to 2019
$1.7M
Integrative methods for high-dimensional genomics dataR01CA160736 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BALADANDAYUTHAPANI, VEERABHADRAN · 2011 to 2014
$1.4M
Proteomic-based integrated subject-specific networks in cancerR21CA220299 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BALADANDAYUTHAPANI, VEERABHADRAN, HA, MIN JIN · 2018 to 2019
$378k
NCATS NIH HHS UL1 TR001878NCI NIH HHS P30 CA046592NCI NIH HHS P50 CA221707NCI NIH HHS R01 CA160736NCI NIH HHS R01 CA178744NCI NIH HHS R01 CA244845NCI NIH HHS R21 CA220299NSF 1463233T-32 NIH training CA-178744T-32 NIH training CA221707T-32 NIH training CA244845T-32 NIH training NIH R01-CA244845T-32 NIH training P30 CA46592T-32 NIH training P50-CA221707T-32 NIH training R01-CA160736T-32 NIH training R01-CA178744T-32 NIH training R01-CA244845-01 A1T-32 NIH training R21-CA220299T-32 NIH training UL1-TR001878
6 · The paper itself

Abstract

Cancer cell lines serve as model in vitro systems for investigating therapeutic interventions. Recent advances in high-throughput genomic profiling have enabled the systematic comparison between cell lines and patient tumor samples. The highly interconnected nature of biological data, however, presents a challenge when mapping patient tumors to cell lines. Standard clustering methods can be particularly susceptible to the high level of noise present in these datasets and only output clusters at one unknown scale of the data. In light of these challenges, we present NetCellMatch, a robust framework for network-based matching of cell lines to patient tumors. NetCellMatch first constructs a global network across all cell line-patient samples using their genomic similarity. Then, a multi-scale community detection algorithm integrates information across topologically meaningful (clustering) scales to obtain Network-Based Matching Scores (NBMS). NBMS are measures of cluster robustness which map patient tumors to cell lines. We use NBMS to determine representative "avatar" cell lines for subgroups of patients. We apply NetCellMatch to reverse-phase protein array data obtained from The Cancer Genome Atlas for patients and the MD Anderson Cell Line Project for cell lines. Along with avatar cell line identification, we evaluate connectivity patterns for breast, lung, and colon cancer and explore the proteomic profiles of avatars and their corresponding top matching patients. Our results demonstrate our framework's ability to identify both patient-cell line matches and potential proteomic drivers of similarity. Our methods are general and can be easily adapted to other'omic datasets.

Indexed as

NeoplasmsProteomicsCell LineHumans

Identifiers

PMID36279370
PMCPMC10066864

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.